家庭参与式尊严疗法对中晚期宫颈癌患者情绪状态及病耻感的影响

Effects of family participatory dignity therapy on emotional state and stigma in patients with cervical cancer during middle and late period

目的探讨家庭参与式尊严疗法对中晚期宫颈癌患者情绪状态及病耻感的影响。方法选择2022年10月至2023年10月本院收治的160例中晚期宫颈癌患者,按照随机数字表法将其分为对照组(80例,常规护理干预)和研究组(80例,家庭参与式尊严疗法)。比较两组的干预效果。结果干预后,两组的焦虑、抑郁评分均低于干预前,且研究组低于对照组(P<0.05)。干预后,两组的疏离因子、歧视经历因子、刻板认同因子、社会退缩因子及病耻感抵抗因子评分均低于干预前,且研究组低于对照组(P<0.05)。干预后,两组的外表自尊、社会自尊、行为自尊评分及总分均高于干预前,且研究组高于对照组(P<0.05)。研究组的满意度高于对照组(P<0.05)。结论家庭参与式尊严疗法可缓解中晚期宫颈癌患者焦虑、抑郁情绪,减轻病耻感,增强自尊感,并提升满意度。

Objective To explore the effects of family participatory dignity therapy on emotional state and stigma in patients with cervical cancer during middle and late period.Methods A total of 160 patients with cervical cancer during middle and late period admitted in our hospital from October 2022 to October 2023 were selected and divided into control group(80 cases,routine nursing intervention)and study group(80 cases,family participatory dignity therapy)according to random number table method.The intervention effects of the two groups were compared.Results After intervention,the scores of anxiety and depression in both groups were lower than those before intervention,and those in the study group were lower than the control group(P<0.05).After intervention,the scores of alienation factor,discrimination experience factor,stereotypical identity factor,social withdrawal factor and stigma resistance factor in both groups were lower than those before intervention,and those in the study group were lower than the control group(P<0.05).After intervention,the appearance self-esteem,social self-esteem and behavioral self-esteem scores and total score in both groups were higher than those before intervention,and those in the study group were higher than the control group(P<0.05).The satisfaction of the study group was higher than that of the control group(P<0.05).Conclusion Family participatory dignity therapy can relieve anxiety and depression,reduce stigma,enhance self-esteem,and enhance satisfaction in patients with cervical cancer during middle and late period.